“…A mouse model with pretransplant BMT as well as CD28/B7 and lymphocyte function associated antigen-1 antagonism followed by skin transplantation 4 to 6 weeks after treatment and subsequently heart transplantation 2 weeks later showed induction of long-term donor-specific tolerance of heart allografts, but chronically rejected skin grafts of the same background as the BMT and heart. 17 Although this brings both costimulation blockade and mixed chimerism via BMT closer to clinical relevance, the requirement of receiving a BMT and costimulation treatment 1 to 2 months before a heart transplant remains a significant limitation.…”
Donor-specific tolerance for heart transplant can be influenced by costimulation blockade, cell-based targets, or mixed chimerism. Thymic interventions are poised to propel the field into translation.
“…A mouse model with pretransplant BMT as well as CD28/B7 and lymphocyte function associated antigen-1 antagonism followed by skin transplantation 4 to 6 weeks after treatment and subsequently heart transplantation 2 weeks later showed induction of long-term donor-specific tolerance of heart allografts, but chronically rejected skin grafts of the same background as the BMT and heart. 17 Although this brings both costimulation blockade and mixed chimerism via BMT closer to clinical relevance, the requirement of receiving a BMT and costimulation treatment 1 to 2 months before a heart transplant remains a significant limitation.…”
Donor-specific tolerance for heart transplant can be influenced by costimulation blockade, cell-based targets, or mixed chimerism. Thymic interventions are poised to propel the field into translation.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.